nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—KCNQ4—cochlea—brain cancer	0.0804	0.204	CbGeAlD
Ezogabine—KCNQ4—internal ear—brain cancer	0.0762	0.194	CbGeAlD
Ezogabine—NAT2—pineal body—brain cancer	0.0509	0.129	CbGeAlD
Ezogabine—UGT1A1—Etoposide—brain cancer	0.0429	1	CbGbCtD
Ezogabine—Neurological symptom—Lomustine—brain cancer	0.0361	0.0703	CcSEcCtD
Ezogabine—Dysphasia—Temozolomide—brain cancer	0.0192	0.0373	CcSEcCtD
Ezogabine—Balance disorder—Procarbazine—brain cancer	0.0127	0.0246	CcSEcCtD
Ezogabine—Dysarthria—Lomustine—brain cancer	0.0115	0.0224	CcSEcCtD
Ezogabine—KCNQ2—brainstem—brain cancer	0.00997	0.0253	CbGeAlD
Ezogabine—Nystagmus—Procarbazine—brain cancer	0.00968	0.0189	CcSEcCtD
Ezogabine—KCNQ3—telencephalon—brain cancer	0.00961	0.0244	CbGeAlD
Ezogabine—NAT2—endocrine gland—brain cancer	0.00889	0.0226	CbGeAlD
Ezogabine—KCNQ2—telencephalon—brain cancer	0.00885	0.0225	CbGeAlD
Ezogabine—Disorientation—Lomustine—brain cancer	0.00884	0.0172	CcSEcCtD
Ezogabine—KCNQ5—midbrain—brain cancer	0.0086	0.0219	CbGeAlD
Ezogabine—Osteoarthritis—Lomustine—brain cancer	0.00791	0.0154	CcSEcCtD
Ezogabine—KCNQ4—head—brain cancer	0.00767	0.0195	CbGeAlD
Ezogabine—KCNQ3—medulla oblongata—brain cancer	0.00755	0.0192	CbGeAlD
Ezogabine—KCNQ5—head—brain cancer	0.00746	0.019	CbGeAlD
Ezogabine—KCNQ2—gonad—brain cancer	0.00738	0.0188	CbGeAlD
Ezogabine—Dysarthria—Procarbazine—brain cancer	0.00731	0.0142	CcSEcCtD
Ezogabine—KCNQ2—pituitary gland—brain cancer	0.0072	0.0183	CbGeAlD
Ezogabine—KCNQ3—midbrain—brain cancer	0.0069	0.0176	CbGeAlD
Ezogabine—KCNQ4—cerebellum—brain cancer	0.00684	0.0174	CbGeAlD
Ezogabine—KCNQ5—central nervous system—brain cancer	0.00681	0.0173	CbGeAlD
Ezogabine—Encephalopathy—Carmustine—brain cancer	0.00674	0.0131	CcSEcCtD
Ezogabine—UGT1A3—endocrine gland—brain cancer	0.00674	0.0171	CbGeAlD
Ezogabine—Aphasia—Carmustine—brain cancer	0.00667	0.013	CcSEcCtD
Ezogabine—Aphasia—Temozolomide—brain cancer	0.00645	0.0126	CcSEcCtD
Ezogabine—Hypokinesia—Carmustine—brain cancer	0.00641	0.0125	CcSEcCtD
Ezogabine—Coma—Procarbazine—brain cancer	0.00632	0.0123	CcSEcCtD
Ezogabine—KCNQ3—head—brain cancer	0.00599	0.0152	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—brain cancer	0.00573	0.0146	CbGeAlD
Ezogabine—Disorientation—Procarbazine—brain cancer	0.00561	0.0109	CcSEcCtD
Ezogabine—KCNQ2—endocrine gland—brain cancer	0.00558	0.0142	CbGeAlD
Ezogabine—KCNQ4—brain—brain cancer	0.00556	0.0141	CbGeAlD
Ezogabine—KCNQ2—head—brain cancer	0.00551	0.014	CbGeAlD
Ezogabine—KCNQ3—central nervous system—brain cancer	0.00546	0.0139	CbGeAlD
Ezogabine—KCNQ5—brain—brain cancer	0.00541	0.0137	CbGeAlD
Ezogabine—KCNQ3—cerebellum—brain cancer	0.00534	0.0136	CbGeAlD
Ezogabine—Memory impairment—Temozolomide—brain cancer	0.00533	0.0104	CcSEcCtD
Ezogabine—Visual impairment—Lomustine—brain cancer	0.00527	0.0103	CcSEcCtD
Ezogabine—KCNQ2—central nervous system—brain cancer	0.00503	0.0128	CbGeAlD
Ezogabine—Diplopia—Procarbazine—brain cancer	0.00502	0.00978	CcSEcCtD
Ezogabine—KCNQ2—cerebellum—brain cancer	0.00492	0.0125	CbGeAlD
Ezogabine—Alopecia—Lomustine—brain cancer	0.00483	0.00942	CcSEcCtD
Ezogabine—Disturbance in attention—Temozolomide—brain cancer	0.00483	0.0094	CcSEcCtD
Ezogabine—UGT1A9—endocrine gland—brain cancer	0.0048	0.0122	CbGeAlD
Ezogabine—UGT1A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00455	0.0905	CbGpPWpGaD
Ezogabine—Gait disturbance—Carmustine—brain cancer	0.00443	0.00863	CcSEcCtD
Ezogabine—Infection—Carboplatin—brain cancer	0.00441	0.0086	CcSEcCtD
Ezogabine—Coordination abnormal—Carmustine—brain cancer	0.00441	0.00858	CcSEcCtD
Ezogabine—Disorientation—Hydroxyurea—brain cancer	0.00434	0.00846	CcSEcCtD
Ezogabine—Dysphagia—Procarbazine—brain cancer	0.00434	0.00845	CcSEcCtD
Ezogabine—KCNQ3—brain—brain cancer	0.00434	0.011	CbGeAlD
Ezogabine—Gait disturbance—Temozolomide—brain cancer	0.00428	0.00834	CcSEcCtD
Ezogabine—Leukopenia—Lomustine—brain cancer	0.00426	0.0083	CcSEcCtD
Ezogabine—Coordination abnormal—Temozolomide—brain cancer	0.00426	0.00829	CcSEcCtD
Ezogabine—KCNQ2—brain—brain cancer	0.00399	0.0102	CbGeAlD
Ezogabine—Coma—Carmustine—brain cancer	0.00395	0.0077	CcSEcCtD
Ezogabine—Infection—Lomustine—brain cancer	0.00386	0.00752	CcSEcCtD
Ezogabine—Thrombocytopenia—Lomustine—brain cancer	0.00381	0.00741	CcSEcCtD
Ezogabine—Skin discolouration—Etoposide—brain cancer	0.0037	0.00722	CcSEcCtD
Ezogabine—Haematuria—Procarbazine—brain cancer	0.00369	0.00718	CcSEcCtD
Ezogabine—Hallucination—Procarbazine—brain cancer	0.00346	0.00673	CcSEcCtD
Ezogabine—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00338	0.0672	CbGpPWpGaD
Ezogabine—Amnesia—Carmustine—brain cancer	0.00334	0.00651	CcSEcCtD
Ezogabine—UGT1A1—endocrine gland—brain cancer	0.00329	0.00836	CbGeAlD
Ezogabine—UGT1A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00325	0.0646	CbGpPWpGaD
Ezogabine—Amnesia—Temozolomide—brain cancer	0.00323	0.00629	CcSEcCtD
Ezogabine—Diplopia—Carmustine—brain cancer	0.00314	0.00612	CcSEcCtD
Ezogabine—Neutropenia—Hydroxyurea—brain cancer	0.00314	0.00612	CcSEcCtD
Ezogabine—Dysuria—Hydroxyurea—brain cancer	0.00314	0.00612	CcSEcCtD
Ezogabine—Alopecia—Procarbazine—brain cancer	0.00307	0.00598	CcSEcCtD
Ezogabine—Weight increased—Hydroxyurea—brain cancer	0.00306	0.00595	CcSEcCtD
Ezogabine—Diplopia—Temozolomide—brain cancer	0.00304	0.00591	CcSEcCtD
Ezogabine—Infestation—Hydroxyurea—brain cancer	0.00299	0.00583	CcSEcCtD
Ezogabine—Infestation NOS—Hydroxyurea—brain cancer	0.00299	0.00583	CcSEcCtD
Ezogabine—Liver function test abnormal—Carmustine—brain cancer	0.0029	0.00565	CcSEcCtD
Ezogabine—Tremor—Procarbazine—brain cancer	0.00283	0.00552	CcSEcCtD
Ezogabine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00283	0.00552	CcSEcCtD
Ezogabine—Dysphagia—Carmustine—brain cancer	0.00271	0.00529	CcSEcCtD
Ezogabine—Syncope—Procarbazine—brain cancer	0.00271	0.00528	CcSEcCtD
Ezogabine—Leukopenia—Procarbazine—brain cancer	0.00271	0.00527	CcSEcCtD
Ezogabine—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0027	0.0537	CbGpPWpGaD
Ezogabine—Hallucination—Hydroxyurea—brain cancer	0.00267	0.00521	CcSEcCtD
Ezogabine—Loss of consciousness—Procarbazine—brain cancer	0.00266	0.00518	CcSEcCtD
Ezogabine—Dysphagia—Temozolomide—brain cancer	0.00262	0.00511	CcSEcCtD
Ezogabine—Anxiety—Procarbazine—brain cancer	0.00257	0.005	CcSEcCtD
Ezogabine—Neutropenia—Carmustine—brain cancer	0.00254	0.00494	CcSEcCtD
Ezogabine—Dry mouth—Procarbazine—brain cancer	0.00252	0.0049	CcSEcCtD
Ezogabine—Confusional state—Procarbazine—brain cancer	0.00249	0.00485	CcSEcCtD
Ezogabine—Dysuria—Temozolomide—brain cancer	0.00245	0.00478	CcSEcCtD
Ezogabine—Neutropenia—Temozolomide—brain cancer	0.00245	0.00478	CcSEcCtD
Ezogabine—Infection—Procarbazine—brain cancer	0.00245	0.00477	CcSEcCtD
Ezogabine—CYP2A6—cerebellum—brain cancer	0.00244	0.00621	CbGeAlD
Ezogabine—Shock—Procarbazine—brain cancer	0.00243	0.00473	CcSEcCtD
Ezogabine—Thrombocytopenia—Procarbazine—brain cancer	0.00242	0.00471	CcSEcCtD
Ezogabine—Weight increased—Temozolomide—brain cancer	0.00239	0.00465	CcSEcCtD
Ezogabine—Hyperhidrosis—Procarbazine—brain cancer	0.00239	0.00465	CcSEcCtD
Ezogabine—Alopecia—Hydroxyurea—brain cancer	0.00238	0.00463	CcSEcCtD
Ezogabine—Infestation—Temozolomide—brain cancer	0.00234	0.00456	CcSEcCtD
Ezogabine—Infestation NOS—Temozolomide—brain cancer	0.00234	0.00456	CcSEcCtD
Ezogabine—Nausea—Lomustine—brain cancer	0.00231	0.0045	CcSEcCtD
Ezogabine—Paraesthesia—Procarbazine—brain cancer	0.00222	0.00432	CcSEcCtD
Ezogabine—Hepatobiliary disease—Temozolomide—brain cancer	0.00221	0.00431	CcSEcCtD
Ezogabine—Somnolence—Procarbazine—brain cancer	0.00219	0.00427	CcSEcCtD
Ezogabine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00217	0.00423	CcSEcCtD
Ezogabine—Hallucination—Carmustine—brain cancer	0.00216	0.00421	CcSEcCtD
Ezogabine—Oedema peripheral—Carmustine—brain cancer	0.00214	0.00417	CcSEcCtD
Ezogabine—Fatigue—Procarbazine—brain cancer	0.00213	0.00414	CcSEcCtD
Ezogabine—Malaise—Hydroxyurea—brain cancer	0.00211	0.00411	CcSEcCtD
Ezogabine—Constipation—Procarbazine—brain cancer	0.00211	0.00411	CcSEcCtD
Ezogabine—Dysphagia—Etoposide—brain cancer	0.0021	0.00409	CcSEcCtD
Ezogabine—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.0021	0.0417	CbGpPWpGaD
Ezogabine—Leukopenia—Hydroxyurea—brain cancer	0.00209	0.00408	CcSEcCtD
Ezogabine—Visual impairment—Carmustine—brain cancer	0.00209	0.00408	CcSEcCtD
Ezogabine—Hallucination—Temozolomide—brain cancer	0.00209	0.00407	CcSEcCtD
Ezogabine—Urinary tract disorder—Temozolomide—brain cancer	0.00207	0.00404	CcSEcCtD
Ezogabine—Oedema peripheral—Temozolomide—brain cancer	0.00207	0.00403	CcSEcCtD
Ezogabine—Urethral disorder—Temozolomide—brain cancer	0.00206	0.00401	CcSEcCtD
Ezogabine—Feeling abnormal—Procarbazine—brain cancer	0.00203	0.00396	CcSEcCtD
Ezogabine—Eye disorder—Carmustine—brain cancer	0.00203	0.00396	CcSEcCtD
Ezogabine—Visual impairment—Temozolomide—brain cancer	0.00202	0.00394	CcSEcCtD
Ezogabine—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00202	0.0401	CbGpPWpGaD
Ezogabine—CYP2A6—brain—brain cancer	0.00198	0.00504	CbGeAlD
Ezogabine—Discomfort—Hydroxyurea—brain cancer	0.00197	0.00383	CcSEcCtD
Ezogabine—Neutropenia—Etoposide—brain cancer	0.00196	0.00382	CcSEcCtD
Ezogabine—Eye disorder—Temozolomide—brain cancer	0.00196	0.00382	CcSEcCtD
Ezogabine—Alopecia—Carmustine—brain cancer	0.00192	0.00374	CcSEcCtD
Ezogabine—Mental disorder—Carmustine—brain cancer	0.0019	0.00371	CcSEcCtD
Ezogabine—Infection—Hydroxyurea—brain cancer	0.0019	0.0037	CcSEcCtD
Ezogabine—Malnutrition—Carmustine—brain cancer	0.00189	0.00368	CcSEcCtD
Ezogabine—Nervous system disorder—Hydroxyurea—brain cancer	0.00187	0.00365	CcSEcCtD
Ezogabine—Infestation—Etoposide—brain cancer	0.00187	0.00365	CcSEcCtD
Ezogabine—Infestation NOS—Etoposide—brain cancer	0.00187	0.00365	CcSEcCtD
Ezogabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00187	0.00364	CcSEcCtD
Ezogabine—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00187	0.0371	CbGpPWpGaD
Ezogabine—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00187	0.0371	CbGpPWpGaD
Ezogabine—Alopecia—Temozolomide—brain cancer	0.00186	0.00361	CcSEcCtD
Ezogabine—Mental disorder—Temozolomide—brain cancer	0.00184	0.00358	CcSEcCtD
Ezogabine—Malnutrition—Temozolomide—brain cancer	0.00183	0.00356	CcSEcCtD
Ezogabine—Vision blurred—Carmustine—brain cancer	0.00178	0.00347	CcSEcCtD
Ezogabine—Tremor—Carmustine—brain cancer	0.00177	0.00345	CcSEcCtD
Ezogabine—Asthenia—Procarbazine—brain cancer	0.00177	0.00345	CcSEcCtD
Ezogabine—Hepatobiliary disease—Etoposide—brain cancer	0.00177	0.00345	CcSEcCtD
Ezogabine—Vision blurred—Temozolomide—brain cancer	0.00172	0.00336	CcSEcCtD
Ezogabine—Tremor—Temozolomide—brain cancer	0.00171	0.00334	CcSEcCtD
Ezogabine—Dyspnoea—Hydroxyurea—brain cancer	0.0017	0.00332	CcSEcCtD
Ezogabine—Somnolence—Hydroxyurea—brain cancer	0.0017	0.00331	CcSEcCtD
Ezogabine—Ill-defined disorder—Temozolomide—brain cancer	0.0017	0.0033	CcSEcCtD
Ezogabine—Leukopenia—Carmustine—brain cancer	0.00169	0.0033	CcSEcCtD
Ezogabine—Dyspepsia—Hydroxyurea—brain cancer	0.00168	0.00327	CcSEcCtD
Ezogabine—Urinary tract disorder—Etoposide—brain cancer	0.00166	0.00323	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00165	0.00321	CcSEcCtD
Ezogabine—Malaise—Temozolomide—brain cancer	0.00165	0.00321	CcSEcCtD
Ezogabine—Urethral disorder—Etoposide—brain cancer	0.00165	0.00321	CcSEcCtD
Ezogabine—Fatigue—Hydroxyurea—brain cancer	0.00165	0.00321	CcSEcCtD
Ezogabine—Vertigo—Temozolomide—brain cancer	0.00164	0.0032	CcSEcCtD
Ezogabine—Leukopenia—Temozolomide—brain cancer	0.00164	0.00319	CcSEcCtD
Ezogabine—Constipation—Hydroxyurea—brain cancer	0.00163	0.00318	CcSEcCtD
Ezogabine—Dizziness—Procarbazine—brain cancer	0.00163	0.00318	CcSEcCtD
Ezogabine—Anxiety—Carmustine—brain cancer	0.0016	0.00313	CcSEcCtD
Ezogabine—Feeling abnormal—Hydroxyurea—brain cancer	0.00157	0.00307	CcSEcCtD
Ezogabine—Eye disorder—Etoposide—brain cancer	0.00157	0.00306	CcSEcCtD
Ezogabine—Confusional state—Carmustine—brain cancer	0.00156	0.00303	CcSEcCtD
Ezogabine—Rash—Procarbazine—brain cancer	0.00156	0.00303	CcSEcCtD
Ezogabine—Dermatitis—Procarbazine—brain cancer	0.00155	0.00303	CcSEcCtD
Ezogabine—Anxiety—Temozolomide—brain cancer	0.00155	0.00302	CcSEcCtD
Ezogabine—Discomfort—Temozolomide—brain cancer	0.00154	0.00299	CcSEcCtD
Ezogabine—Infection—Carmustine—brain cancer	0.00153	0.00299	CcSEcCtD
Ezogabine—Dry mouth—Temozolomide—brain cancer	0.00152	0.00296	CcSEcCtD
Ezogabine—Thrombocytopenia—Carmustine—brain cancer	0.00151	0.00294	CcSEcCtD
Ezogabine—Confusional state—Temozolomide—brain cancer	0.0015	0.00293	CcSEcCtD
Ezogabine—Alopecia—Etoposide—brain cancer	0.00148	0.00289	CcSEcCtD
Ezogabine—Infection—Temozolomide—brain cancer	0.00148	0.00289	CcSEcCtD
Ezogabine—Nausea—Procarbazine—brain cancer	0.00147	0.00285	CcSEcCtD
Ezogabine—Nervous system disorder—Temozolomide—brain cancer	0.00146	0.00285	CcSEcCtD
Ezogabine—Thrombocytopenia—Temozolomide—brain cancer	0.00146	0.00284	CcSEcCtD
Ezogabine—Hyperhidrosis—Temozolomide—brain cancer	0.00144	0.00281	CcSEcCtD
Ezogabine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00144	0.0286	CbGpPWpGaD
Ezogabine—Muscle spasms—Etoposide—brain cancer	0.00141	0.00274	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP2C9—brain cancer	0.0014	0.0278	CbGpPWpGaD
Ezogabine—Paraesthesia—Carmustine—brain cancer	0.00139	0.0027	CcSEcCtD
Ezogabine—NAT2—Metapathway biotransformation—CYP2C9—brain cancer	0.00138	0.0274	CbGpPWpGaD
Ezogabine—Dyspnoea—Carmustine—brain cancer	0.00138	0.00268	CcSEcCtD
Ezogabine—Somnolence—Carmustine—brain cancer	0.00137	0.00267	CcSEcCtD
Ezogabine—Asthenia—Hydroxyurea—brain cancer	0.00137	0.00267	CcSEcCtD
Ezogabine—Ill-defined disorder—Etoposide—brain cancer	0.00136	0.00264	CcSEcCtD
Ezogabine—Paraesthesia—Temozolomide—brain cancer	0.00134	0.00261	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Carmustine—brain cancer	0.00133	0.0026	CcSEcCtD
Ezogabine—Dyspnoea—Temozolomide—brain cancer	0.00133	0.00259	CcSEcCtD
Ezogabine—Somnolence—Temozolomide—brain cancer	0.00133	0.00258	CcSEcCtD
Ezogabine—Constipation—Carmustine—brain cancer	0.00132	0.00257	CcSEcCtD
Ezogabine—Malaise—Etoposide—brain cancer	0.00132	0.00257	CcSEcCtD
Ezogabine—Vertigo—Etoposide—brain cancer	0.00131	0.00256	CcSEcCtD
Ezogabine—Dyspepsia—Temozolomide—brain cancer	0.00131	0.00256	CcSEcCtD
Ezogabine—Leukopenia—Etoposide—brain cancer	0.00131	0.00255	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00129	0.00251	CcSEcCtD
Ezogabine—Fatigue—Temozolomide—brain cancer	0.00129	0.00251	CcSEcCtD
Ezogabine—Loss of consciousness—Etoposide—brain cancer	0.00129	0.0025	CcSEcCtD
Ezogabine—Constipation—Temozolomide—brain cancer	0.00128	0.00248	CcSEcCtD
Ezogabine—Feeling abnormal—Carmustine—brain cancer	0.00127	0.00248	CcSEcCtD
Ezogabine—Dizziness—Hydroxyurea—brain cancer	0.00126	0.00246	CcSEcCtD
Ezogabine—Discomfort—Etoposide—brain cancer	0.00123	0.0024	CcSEcCtD
Ezogabine—Feeling abnormal—Temozolomide—brain cancer	0.00123	0.00239	CcSEcCtD
Ezogabine—Rash—Hydroxyurea—brain cancer	0.0012	0.00235	CcSEcCtD
Ezogabine—Confusional state—Etoposide—brain cancer	0.0012	0.00234	CcSEcCtD
Ezogabine—Dermatitis—Hydroxyurea—brain cancer	0.0012	0.00234	CcSEcCtD
Ezogabine—Infection—Etoposide—brain cancer	0.00119	0.00231	CcSEcCtD
Ezogabine—Thrombocytopenia—Etoposide—brain cancer	0.00117	0.00228	CcSEcCtD
Ezogabine—Hyperhidrosis—Etoposide—brain cancer	0.00115	0.00225	CcSEcCtD
Ezogabine—Nausea—Hydroxyurea—brain cancer	0.00113	0.00221	CcSEcCtD
Ezogabine—Asthenia—Carmustine—brain cancer	0.00111	0.00216	CcSEcCtD
Ezogabine—Paraesthesia—Etoposide—brain cancer	0.00107	0.00209	CcSEcCtD
Ezogabine—Asthenia—Temozolomide—brain cancer	0.00107	0.00208	CcSEcCtD
Ezogabine—Dyspnoea—Etoposide—brain cancer	0.00106	0.00207	CcSEcCtD
Ezogabine—Somnolence—Etoposide—brain cancer	0.00106	0.00207	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Etoposide—brain cancer	0.00103	0.00201	CcSEcCtD
Ezogabine—Fatigue—Etoposide—brain cancer	0.00103	0.002	CcSEcCtD
Ezogabine—Dizziness—Carmustine—brain cancer	0.00102	0.00199	CcSEcCtD
Ezogabine—Constipation—Etoposide—brain cancer	0.00102	0.00199	CcSEcCtD
Ezogabine—Dizziness—Temozolomide—brain cancer	0.000987	0.00192	CcSEcCtD
Ezogabine—Feeling abnormal—Etoposide—brain cancer	0.000984	0.00192	CcSEcCtD
Ezogabine—Rash—Carmustine—brain cancer	0.000973	0.0019	CcSEcCtD
Ezogabine—Dermatitis—Carmustine—brain cancer	0.000973	0.00189	CcSEcCtD
Ezogabine—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000959	0.0191	CbGpPWpGaD
Ezogabine—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000959	0.0191	CbGpPWpGaD
Ezogabine—Rash—Temozolomide—brain cancer	0.000941	0.00183	CcSEcCtD
Ezogabine—Dermatitis—Temozolomide—brain cancer	0.00094	0.00183	CcSEcCtD
Ezogabine—Nausea—Carmustine—brain cancer	0.000917	0.00179	CcSEcCtD
Ezogabine—Nausea—Temozolomide—brain cancer	0.000886	0.00173	CcSEcCtD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000874	0.0174	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000871	0.0173	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000859	0.0171	CbGpPWpGaD
Ezogabine—Asthenia—Etoposide—brain cancer	0.000857	0.00167	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—CYP2C9—brain cancer	0.000847	0.0168	CbGpPWpGaD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000835	0.0166	CbGpPWpGaD
Ezogabine—Dizziness—Etoposide—brain cancer	0.000789	0.00154	CcSEcCtD
Ezogabine—Rash—Etoposide—brain cancer	0.000753	0.00147	CcSEcCtD
Ezogabine—Dermatitis—Etoposide—brain cancer	0.000752	0.00146	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000726	0.0144	CbGpPWpGaD
Ezogabine—Nausea—Etoposide—brain cancer	0.000709	0.00138	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000706	0.014	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000704	0.014	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000694	0.0138	CbGpPWpGaD
Ezogabine—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000621	0.0123	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000502	0.00997	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000502	0.00997	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000486	0.00967	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000486	0.00967	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00048	0.00953	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.00048	0.00953	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000454	0.00902	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—TRPC6—brain cancer	0.000441	0.00877	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—TRPC6—brain cancer	0.000441	0.00877	CbGpPWpGaD
Ezogabine—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000401	0.00797	CbGpPWpGaD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000397	0.0079	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000377	0.0075	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000375	0.00745	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000347	0.0069	CbGpPWpGaD
Ezogabine—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.000322	0.00639	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TRPC6—brain cancer	0.000315	0.00626	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TRPC6—brain cancer	0.000315	0.00626	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—EGFR—brain cancer	0.000299	0.00594	CbGpPWpGaD
Ezogabine—KCNQ3—L1CAM interactions—EGFR—brain cancer	0.000299	0.00594	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000289	0.00573	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000261	0.00518	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000261	0.00518	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP2C9—brain cancer	0.000239	0.00475	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—BSG—brain cancer	0.000203	0.00404	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HES1—brain cancer	0.000203	0.00403	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HES1—brain cancer	0.000203	0.00403	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000199	0.00396	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000199	0.00396	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000187	0.00371	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—IDH1—brain cancer	0.000175	0.00347	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.000168	0.00334	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—ERBB2—brain cancer	0.000163	0.00324	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—ERBB2—brain cancer	0.000163	0.00324	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CDK4—brain cancer	0.000159	0.00316	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CDK4—brain cancer	0.000159	0.00316	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2C9—brain cancer	0.000145	0.00288	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ENO2—brain cancer	0.000138	0.00275	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000137	0.00271	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—brain cancer	0.000126	0.0025	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—brain cancer	0.000126	0.0025	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BSG—brain cancer	0.000123	0.00245	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2C9—brain cancer	0.00012	0.00239	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—RELA—brain cancer	0.000117	0.00233	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—RELA—brain cancer	0.000117	0.00233	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ERBB2—brain cancer	0.000116	0.00231	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ERBB2—brain cancer	0.000116	0.00231	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—EGFR—brain cancer	0.000113	0.00225	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—EGFR—brain cancer	0.000113	0.00225	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—IDH1—brain cancer	0.000106	0.0021	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BSG—brain cancer	0.000102	0.00203	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CTNNB1—brain cancer	0.000102	0.00202	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CTNNB1—brain cancer	0.000102	0.00202	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—brain cancer	8.96e-05	0.00178	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—brain cancer	8.96e-05	0.00178	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—STAT3—brain cancer	8.87e-05	0.00176	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—STAT3—brain cancer	8.87e-05	0.00176	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—IDH1—brain cancer	8.8e-05	0.00175	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO2—brain cancer	8.37e-05	0.00166	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2C9—brain cancer	8.32e-05	0.00165	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2C9—brain cancer	8.32e-05	0.00165	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—EGFR—brain cancer	8.06e-05	0.0016	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—EGFR—brain cancer	8.06e-05	0.0016	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BSG—brain cancer	7.07e-05	0.00141	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BSG—brain cancer	7.07e-05	0.00141	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO2—brain cancer	6.96e-05	0.00138	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2C9—brain cancer	6.41e-05	0.00127	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CG—brain cancer	6.34e-05	0.00126	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—IDH1—brain cancer	6.08e-05	0.00121	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—IDH1—brain cancer	6.08e-05	0.00121	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BSG—brain cancer	5.45e-05	0.00108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.95e-05	0.000984	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO2—brain cancer	4.81e-05	0.000955	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO2—brain cancer	4.81e-05	0.000955	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—IDH1—brain cancer	4.69e-05	0.000932	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CG—brain cancer	3.84e-05	0.000763	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO2—brain cancer	3.71e-05	0.000736	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CG—brain cancer	3.19e-05	0.000634	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CG—brain cancer	2.21e-05	0.000438	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CG—brain cancer	2.21e-05	0.000438	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CG—brain cancer	1.7e-05	0.000338	CbGpPWpGaD
